A61K 9/1605
Excipients
Official title: {Excipients; Inactive ingredients}
A61K9/1605 (Excipients) appears on 7,365 US grants and 12,132 published applications in this corpus.
Search patents in A61K- Granted patents
- 7,365
- Published applications
- 12,132
- Assignees
- 4,217
- Inventors
- 20,046
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 5 | 0 |
| 1978 | 10 | 0 |
| 1979 | 8 | 0 |
| 1980 | 10 | 0 |
| 1981 | 6 | 0 |
| 1982 | 15 | 0 |
| 1983 | 18 | 0 |
| 1984 | 9 | 0 |
| 1985 | 12 | 0 |
| 1986 | 20 | 0 |
| 1987 | 30 | 0 |
| 1988 | 44 | 0 |
| 1989 | 66 | 0 |
| 1990 | 66 | 0 |
| 1991 | 60 | 0 |
| 1992 | 48 | 0 |
| 1993 | 51 | 0 |
| 1994 | 60 | 0 |
| 1995 | 90 | 0 |
| 1996 | 102 | 0 |
| 1997 | 132 | 0 |
| 1998 | 117 | 0 |
| 1999 | 154 | 0 |
| 2000 | 125 | 0 |
| 2001 | 158 | 75 |
| 2002 | 177 | 282 |
| 2003 | 197 | 399 |
| 2004 | 121 | 410 |
| 2005 | 103 | 402 |
| 2006 | 132 | 371 |
| 2007 | 82 | 405 |
| 2008 | 87 | 438 |
| 2009 | 86 | 409 |
| 2010 | 161 | 505 |
| 2011 | 140 | 431 |
| 2012 | 239 | 446 |
| 2013 | 319 | 472 |
| 2014 | 405 | 518 |
| 2015 | 333 | 543 |
| 2016 | 328 | 582 |
| 2017 | 374 | 641 |
| 2018 | 350 | 463 |
| 2019 | 342 | 528 |
| 2020 | 315 | 592 |
| 2021 | 304 | 631 |
| 2022 | 294 | 614 |
| 2023 | 280 | 591 |
| 2024 | 287 | 536 |
| 2025 | 310 | 455 |
| 2026 | 176 | 393 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Carotenoid preparations, preparation methods, and application thereof6 Oct 2026US 12,751,924 B2Innobio Corporation Limited
- Powder mixing device, and uses thereof6 Oct 2026US 12,751,925 B2University of Connecticut
- Formulation for oral administration, comprising triazine derivative6 Oct 2026US 12,751,955 B2Shionogi & Co., Ltd.
- Formulation to deter abuse of drugs by smoking22 Sep 2026US 12,740,944 B2Purdue Research Foundation
- Pharmaceutical composition and method for enhancing solubility of poorly soluble active pharmaceutical ingredients15 Sep 2026US 12,734,130 B2Merck Patent GmbH
- Hyaluronic acid hydrogels with agent to enhance resorption8 Oct 2026US 2026/0306398 A1Boston Scientific Scimed, Inc.
- Subcutaneous peptide delivery system8 Oct 2026US 2026/0306408 A1
- Drug-containing particle8 Oct 2026US 2026/0306409 A1Towa Pharmaceutical Co., Ltd.
- Composition comprising particles containing reduced coenzyme q108 Oct 2026US 2026/0306424 A1Kaneka Corporation
- Moisture-proof acetyl l-carnitine8 Oct 2026US 2026/0306437 A1Nanjing Nutrabuilding Bio-Tech Co., Ltd.
Most cited
By later US patents
- Polyhydroxyalkanoate compositions having controlled degradation rates1,516US 6,867,248 B1Metabolix, Inc. · 2005
- Particle immobilized coatings and uses thereof1,386US 8,679,454 B2SurModics, Inc. · 2014
- Method for making a bioerodible material for the sustained release of a medicament and the material made from the method1,033US 5,456,917 ACambridge Scientific, Inc. · 1995
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001